SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-22-094075
Filing Date
2022-08-24
Accepted
2022-08-24 17:21:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 tm2224508d2_425.htm 425 20329
2 GRAPHIC tm2224508d2_425img001.jpg GRAPHIC 11503
  Complete submission text file 0001104659-22-094075.txt   32637
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVISTA CAPITAL HOLDINGS, LP 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022
Business Address C/O AVISTA CAPITAL HOLDINGS, LP 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 212-593-6900
Avista Public Acquisition Corp. II (Subject) CIK: 0001846253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40720 | Film No.: 221192347
SIC: 8731 Services-Commercial Physical & Biological Research